Hitag Biotechnology is dedicated to developing recombinant proteins and immunogens without the need for adjuvants. By using a proprietary platform, “Fh8 r-PPure System”, Hitag Biotechnology produces soluble and highly pure recombinant proteins. This platform relies in the smallest solubilisation tag, 8 kDa, which has affinity to hydrophobic purification colums. A second proprietary platform, “H VerImmune Ligand”, conferes to a recombinant antigen the immunogenic features of a peptide. The immunisation procedure of this recombinant immunogen does not require coadministration of adjuvant.
| Website | http://www.hitag.pt |
| Revenue | $5.5 million |
| Employees | View employees |
| Address | Parque Tecnológico De Cantanhedenúcleo 4 Lote 4, Cantanhede, Coimbra 3060-197, PT |
| Phone | +351 913 908 581 |
| Industry | Biotechnology Research, Business Services General, Business Services |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 541711 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies |
Looking for a particular Hitag Biotechnology employee's phone or email?
Hitag Biotechnology Questions
The Hitag Biotechnology annual revenue was $5.5 million in 2026.
Hitag Biotechnology is based in Cantanhede, Coimbra.
The NAICS codes for Hitag Biotechnology are [5417, 541711, 54171, 54, 541].
The SIC codes for Hitag Biotechnology are [873, 87].
Related Companies
